Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer

NCT00087178 is registered in ClinicalTrials.gov with NSABP Foundation Inc as lead sponsor.

NCT NCT00087178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00087178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
Lead sponsor
NSABP Foundation Inc
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2004
Completion date
May 31, 2016
Enrollment
2,722 (actual)
Sites
606

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer